Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Sleep apnoea and endothelial dysfunction: An individual patient data meta-analysis.

Bironneau V, Tamisier R, Trzepizur W, Andriantsitohaina R, Berger M, Goupil F, Joyeux-Faure M, Jullian-Desayes I, Launois S, Le Vaillant M, Martinez MC, Roche F, Pépin JL, Gagnadoux F.

Sleep Med Rev. 2020 Mar 13;52:101309. doi: 10.1016/j.smrv.2020.101309. [Epub ahead of print] Review.

PMID:
32234658
2.

Who May Benefit from Diuretics in OSA? A Propensity Score-Match Observational Study.

Revol B, Jullian-Desayes I, Bailly S, Tamisier R, Grillet Y, Sapène M, Joyeux-Faure M, Pépin JL; OSFP national French registry scientific council.

Chest. 2020 Feb 28. pii: S0012-3692(20)30345-7. doi: 10.1016/j.chest.2020.01.050. [Epub ahead of print]

PMID:
32119859
3.

Hypoxic Exercise Training to Improve Exercise Capacity in Obese Individuals.

Chacaroun S, Borowik A, Vega-Escamilla Y Gonzalez I, Doutreleau S, Wuyam B, Belaidi E, Tamisier R, Pepin JL, Flore P, Verges S.

Med Sci Sports Exerc. 2020 Feb 25. doi: 10.1249/MSS.0000000000002322. [Epub ahead of print]

PMID:
32102058
4.

AVAPS-AE versus ST mode: A randomized controlled trial in patients with obesity hypoventilation syndrome.

Patout M, Gagnadoux F, Rabec C, Trzepizur W, Georges M, Perrin C, Tamisier R, Pépin JL, Llontop C, Attali V, Goutorbe F, Pontier-Marchandise S, Cervantes P, Bironneau V, Portmann A, Delrieu J, Cuvelier A, Muir JF.

Respirology. 2020 Feb 13. doi: 10.1111/resp.13784. [Epub ahead of print]

PMID:
32052923
5.

Valproic acid and sleep apnoea: A disproportionality signal from the WHO pharmacovigilance database.

Revol B, Jullian-Desayes I, Guichard K, Micoulaud-Franchi JA, Tamisier R, Philip P, Joyeux-Faure M, Pépin JL.

Respirology. 2020 Mar;25(3):336-338. doi: 10.1111/resp.13771. Epub 2020 Jan 30. No abstract available.

6.

Pitolisant for Daytime Sleepiness in Obstructive Sleep Apnea Patients Refusing CPAP: A Randomized Trial.

Dauvilliers Y, Verbraecken J, Partinen M, Hedner J, Saaresranta T, Georgiev O, Tiholov R, Lecomte I, Tamisier R, Lévy P, Scart-Gres C, Lecomte JM, Schwartz JC, Pépin JL; HAROSA II study group.

Am J Respir Crit Care Med. 2020 Jan 9. doi: 10.1164/rccm.201907-1284OC. [Epub ahead of print]

PMID:
31917607
7.

Impact of obstructive sleep apnea on the obesity paradox in critically ill patients.

Bailly S, Galerneau LM, Ruckly S, Seiller A, Terzi N, Schwebel C, Dupuis C, Tamisier R, Mourvillier B, Pepin JL, Timsit JF.

J Crit Care. 2020 Apr;56:120-124. doi: 10.1016/j.jcrc.2019.12.016. Epub 2019 Dec 20.

PMID:
31896445
8.

[Cardiac dysfunction and the obstructive sleep apnoea syndrome].

Bocquillon V, Destors M, Guzun R, Doutreleau S, Pépin JL, Tamisier R.

Rev Mal Respir. 2020 Feb;37(2):161-170. doi: 10.1016/j.rmr.2019.07.011. Epub 2019 Dec 19. Review. French.

PMID:
31866122
9.

Reshaping Sleep Apnea Care: Time for Value-based Strategies.

Pépin JL, Baillieul S, Tamisier R.

Ann Am Thorac Soc. 2019 Dec;16(12):1501-1503. doi: 10.1513/AnnalsATS.201909-670ED. No abstract available.

PMID:
31774319
10.

Prevalence of obstructive sleep apnea syndrome in patients with lymphedema referred for complete decongestive therapy.

Roux C, Villemur B, Giovannoni B, Koeyemelk L, Mendelson M, Benmerad M, Joyeux-Faure M, Tamisier R, Pepin JL.

J Vasc Surg Venous Lymphat Disord. 2020 Jan;8(1):137-142. doi: 10.1016/j.jvsv.2019.07.007. Epub 2019 Oct 18.

PMID:
31636050
11.

Sleep duration and architecture during ASV for central sleep apnoea in systolic heart failure.

Roder F, Wellmann B, Bitter T, Fox H, Türoff A, Spiesshoefer J, Tamisier R, Horstkotte D, Oldenburg O.

Respir Physiol Neurobiol. 2020 Jan;271:103286. doi: 10.1016/j.resp.2019.103286. Epub 2019 Sep 14.

PMID:
31526873
12.

Comparison of Auto- and Fixed-Continuous Positive Airway Pressure on Air Leak in Patients with Obstructive Sleep Apnea: Data from a Randomized Controlled Trial.

Lebret M, Rotty MC, Argento C, Pepin JL, Tamisier R, Arbib F, Jaffuel D, Molinari N, Borel JC.

Can Respir J. 2019 Aug 7;2019:6310956. doi: 10.1155/2019/6310956. eCollection 2019.

13.

Big Data in sleep apnoea: Opportunities and challenges.

Pépin JL, Bailly S, Tamisier R.

Respirology. 2019 Aug 14. doi: 10.1111/resp.13669. [Epub ahead of print] Review.

14.

Partial failure of CPAP treatment for sleep apnoea: Analysis of the French national sleep database.

Bailly S, Daabek N, Jullian-Desayes I, Joyeux-Faure M, Sapène M, Grillet Y, Borel JC, Tamisier R, Pépin JL.

Respirology. 2020 Jan;25(1):104-111. doi: 10.1111/resp.13650. Epub 2019 Jul 23.

15.

Validation of an apnea and hypopnea detection algorithm implemented in implantable cardioverter defibrillators. The AIRLESS study.

Defaye P, Mendelson M, Tamisier R, Jacon P, Venier S, Arnol N, Pépin JL.

Sci Rep. 2019 Jul 3;9(1):9597. doi: 10.1038/s41598-019-45255-3.

16.

Adipose tissue as a key player in obstructive sleep apnoea.

Ryan S, Arnaud C, Fitzpatrick SF, Gaucher J, Tamisier R, Pépin JL.

Eur Respir Rev. 2019 Jun 26;28(152). pii: 190006. doi: 10.1183/16000617.0006-2019. Print 2019 Jun 30. Review.

17.

Association of serious adverse events with Cheyne-Stokes respiration characteristics in patients with systolic heart failure and central sleep apnoea: A SERVE-Heart Failure substudy analysis.

Javed F, Tamisier R, Pepin JL, Cowie MR, Wegscheider K, Angermann C, d'Ortho MP, Erdmann E, Simonds AK, Somers VK, Teschler H, Levy P, Armitstead J, Woehrle H.

Respirology. 2020 Mar;25(3):305-311. doi: 10.1111/resp.13613. Epub 2019 Jun 20.

18.

Liver Fibrosis, Sleep Apnea and Cardiovascular Events in Stroke Patients.

Viglino D, Baillieul S, Jullian-Desayes I, Joyeux-Faure M, Tamisier R, Pépin JL.

Cerebrovasc Dis. 2019;47(5-6):309-310. doi: 10.1159/000501259. Epub 2019 Jun 19. No abstract available.

19.

Chronic neuromuscular electrical stimulation improves muscle mass and insulin sensitivity in a mouse model.

Lotri-Koffi A, Pauly M, Lemarié E, Godin-Ribuot D, Tamisier R, Pépin JL, Vivodtzev I.

Sci Rep. 2019 May 10;9(1):7252. doi: 10.1038/s41598-019-43696-4.

20.

Heat-moulded versus custom-made mandibular advancement devices for obstructive sleep apnoea: a randomised non-inferiority trial.

Pépin JL, Raymond N, Lacaze O, Aisenberg N, Forcioli J, Bonte E, Bourdin A, Launois S, Tamisier R, Molinari N.

Thorax. 2019 Jul;74(7):667-674. doi: 10.1136/thoraxjnl-2018-212726. Epub 2019 May 3.

PMID:
31053619
21.

Diagnosis and management of central sleep apnea syndrome.

Baillieul S, Revol B, Jullian-Desayes I, Joyeux-Faure M, Tamisier R, Pépin JL.

Expert Rev Respir Med. 2019 Jun;13(6):545-557. doi: 10.1080/17476348.2019.1604226. Epub 2019 Apr 24.

PMID:
31014146
22.

Reduction in sympathetic tone in patients with obstructive sleep apnoea: is fixed CPAP more effective than APAP? A randomised, parallel trial protocol.

Treptow E, Pepin JL, Bailly S, Levy P, Bosc C, Destors M, Woehrle H, Tamisier R.

BMJ Open. 2019 Apr 4;9(4):e024253. doi: 10.1136/bmjopen-2018-024253.

23.

Marital quality, partner's engagement and continuous positive airway pressure adherence in obstructive sleep apnea.

Gentina T, Bailly S, Jounieaux F, Verkindre C, Broussier PM, Guffroy D, Prigent A, Gres JJ, Kabbani J, Kedziora L, Tamisier R, Gentina E, Pépin JL.

Sleep Med. 2019 Mar;55:56-61. doi: 10.1016/j.sleep.2018.12.009. Epub 2018 Dec 26.

PMID:
30771736
24.

Prevalence and Factors Contributing to Daytime and Nocturnal Hypoxemia in Chronic Heart Failure Patients.

Tamisier R, Bocquillon V, Treptow E, Destors M, Salvat M, Borrel E, Pépin JL.

Respiration. 2019;97(3):213-222. doi: 10.1159/000490734. Epub 2019 Jan 17.

PMID:
30654381
25.

Gabapentinoids and sleep apnea syndrome: a safety signal from the WHO pharmacovigilance database.

Revol B, Jullian-Desayes I, Cracowski JL, Tamisier R, Mallaret M, Joyeux-Faure M, Pepin JL.

Sleep. 2019 Feb 1;42(2). doi: 10.1093/sleep/zsy242. No abstract available.

PMID:
30590830
26.

Sex differences in mandibular repositioning device therapy effectiveness in patients with obstructive sleep apnea syndrome.

Vecchierini MF, Attali V, Collet JM, d'Ortho MP, Goutorbe F, Kerbrat JB, Leger D, Lavergne F, Monaca C, Monteyrol PJ, Morin L, Mullens E, Pigearias B, Martin F, Khemliche H, Lerousseau L, Meurice JC; ORCADES investigators, Abedipour D, Allard-Redon A, Aranda A, Attali V, Bavozet F, Becu M, Beruben W, Bessard J, Bonafe I, Boukhana M, Chabrol B, Chatte G, Lebret C, Collet JM, Coste O, Dumont N, Durand-Amat S, D'ortho MP, Elbaum JM, De Santerre OG, Goutorbes F, Grandjean T, Guyot W, Hammer D, Havasi C, Huet P, Kerbrat JB, Khemliche H, Koltes C, Leger D, Lacassagne L, Laur X, Lerousseau L, Liard O, Loisel C, Longuet M, Mallart A, Martin F, Merle Beral F, Meurice JC, Mokhtari Z, Monaca C, Monteyrol PJ, Muir JF, Mullens E, Muller D, Paoli C, Petit FX, Pigearias B, Pradines M, Prigent A, Putterman G, Rey M, Samama M, Tamisier R, Tiberge M, Tison C, Tordjman F, Triolet B, Vacher C, Vecchierini MF, Verain A.

Sleep Breath. 2019 Sep;23(3):837-848. doi: 10.1007/s11325-018-1766-8. Epub 2018 Dec 22.

27.

Multimodal Remote Monitoring of High Cardiovascular Risk Patients With OSA Initiating CPAP: A Randomized Trial.

Pépin JL, Jullian-Desayes I, Sapène M, Treptow E, Joyeux-Faure M, Benmerad M, Bailly S, Grillet Y, Stach B, Richard P, Lévy P, Muir JF, Tamisier R.

Chest. 2019 Apr;155(4):730-739. doi: 10.1016/j.chest.2018.11.007. Epub 2018 Nov 22.

PMID:
30472022
28.

[Reprint of : Management of obstructive sleep apnea syndrome in people living with diabetes: context, screening, indications and treatment modalities: context, screening, indications and treatment modalities: a French position statement].

Borel AL, Tamisier R, Böhme P, Priou P, Avignon A, Benhamou PY, Hanaire H, Pépin JL, Kessler L, Valensi P, Darmon P, Gagnadoux F.

Rev Mal Respir. 2018 Dec;35(10):1067-1089. doi: 10.1016/j.rmr.2018.10.001. Epub 2018 Nov 11. French. No abstract available.

PMID:
30429090
29.

Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary Disease.

Viglino D, Plazanet A, Bailly S, Benmerad M, Jullian-Desayes I, Tamisier R, Leroy V, Zarski JP, Maignan M, Joyeux-Faure M, Pépin JL.

Sci Rep. 2018 Nov 8;8(1):16559. doi: 10.1038/s41598-018-34988-2.

30.

Waist, neck circumferences, waist-to-hip ratio: Which is the best cardiometabolic risk marker in women with severe obesity? The SOON cohort.

Borel AL, Coumes S, Reche F, Ruckly S, Pépin JL, Tamisier R, Wion N, Arvieux C.

PLoS One. 2018 Nov 8;13(11):e0206617. doi: 10.1371/journal.pone.0206617. eCollection 2018.

31.

Effect of mandibular advancement therapy on inflammatory and metabolic biomarkers in patients with severe obstructive sleep apnoea: a randomised controlled trial.

Recoquillon S, Pépin JL, Vielle B, Andriantsitohaina R, Bironneau V, Chouet-Girard F, Fleury B, Goupil F, Launois S, Martinez MC, Meslier N, Nguyen XL, Paris A, Priou P, Tamisier R, Trzepizur W, Gagnadoux F.

Thorax. 2019 May;74(5):496-499. doi: 10.1136/thoraxjnl-2018-212609. Epub 2018 Oct 26.

PMID:
30366971
32.

What is the best treatment strategy for obstructive sleep apnoea-related hypertension?

Revol B, Jullian-Desayes I, Bailly S, Regnaut L, Tamisier R, Pepin JL, Joyeux-Faure M.

Hypertens Res. 2018 Dec;41(12):1070-1072. doi: 10.1038/s41440-018-0114-5. Epub 2018 Oct 15. No abstract available.

PMID:
30323261
33.

Response to letter to editor "Optical coherence tomography (OCT) findings in obstructive sleep apnea" by Piotr Kanclerz.

Mentek M, Aptel F, Godin-Ribuot D, Tamisier R, Pepin JL, Chiquet C.

Sleep Med Rev. 2018 Dec;42:232-233. doi: 10.1016/j.smrv.2018.08.007. Epub 2018 Aug 31. No abstract available.

PMID:
30274745
34.

POLLAR: Impact of air POLLution on Asthma and Rhinitis; a European Institute of Innovation and Technology Health (EIT Health) project.

Bousquet J, Anto JM, Annesi-Maesano I, Dedeu T, Dupas E, Pépin JL, Eyindanga LSZ, Arnavielhe S, Ayache J, Basagana X, Benveniste S, Venturos NC, Chan HK, Cheraitia M, Dauvilliers Y, Garcia-Aymerich J, Jullian-Desayes I, Dinesh C, Laune D, Dac JL, Nujurally I, Pau G, Picard R, Rodo X, Tamisier R, Bewick M, Billo NE, Czarlewski W, Fonseca J, Klimek L, Pfaar O, Bourez JM.

Clin Transl Allergy. 2018 Sep 17;8:36. doi: 10.1186/s13601-018-0221-z. eCollection 2018. Review.

35.

Obstructive sleep apnoea syndrome in patients living with diabetes: Which patients should be screened?

Borel AL, Tamisier R, Böhme P, Priou P, Avignon A, Benhamou PY, Hanaire H, Pépin JL, Kessler L, Valensi P, Darmon P, Gagnadoux F.

Diabetes Metab. 2019 Apr;45(2):91-101. doi: 10.1016/j.diabet.2018.08.006. Epub 2018 Sep 3.

36.

Automated O2 titration improves exercise capacity in patients with hypercapnic chronic obstructive pulmonary disease: a randomised controlled cross-over trial.

Vivodtzev I, L'Her E, Vottero G, Yankoff C, Tamisier R, Maltais F, Lellouche F, Pépin JL.

Thorax. 2019 Mar;74(3):298-301. doi: 10.1136/thoraxjnl-2018-211967. Epub 2018 Aug 30.

PMID:
30166425
37.

Impaired cerebral oxygenation and exercise tolerance in patients with severe obstructive sleep apnea syndrome.

Marillier M, Gruet M, Baillieul S, Wuyam B, Tamisier R, Levy P, Pepin JL, Verges S.

Sleep Med. 2018 Nov;51:37-46. doi: 10.1016/j.sleep.2018.06.013. Epub 2018 Jul 4.

PMID:
30099350
38.

Contribution of obstructive sleep apnoea to arterial stiffness: a meta-analysis using individual patient data.

Joyeux-Faure M, Tamisier R, Borel JC, Millasseau S, Galerneau LM, Destors M, Bailly S, Pepin JL.

Thorax. 2018 Dec;73(12):1146-1151. doi: 10.1136/thoraxjnl-2018-211513. Epub 2018 Jul 21.

PMID:
30032122
39.

Cysteinyl-leukotriene pathway as a new therapeutic target for the treatment of atherosclerosis related to obstructive sleep apnea syndrome.

Gautier-Veyret E, Bäck M, Arnaud C, Belaïdi E, Tamisier R, Lévy P, Arnol N, Perrin M, Pépin JL, Stanke-Labesque F.

Pharmacol Res. 2018 Aug;134:311-319. doi: 10.1016/j.phrs.2018.06.014. Epub 2018 Jun 18.

PMID:
29920371
40.

Servo-Ventilation Therapy for Sleep-Disordered Breathing.

Somers V, Arzt M, Bradley TD, Randerath W, Tamisier R, Won C.

Chest. 2018 Jun;153(6):1501-1502. doi: 10.1016/j.chest.2018.03.052. Review.

PMID:
29884256
41.

Continuous Positive Airway Pressure Reduces Night-Time Blood Pressure and Heart Rate in Patients With Obstructive Sleep Apnea and Resistant Hypertension: The RHOOSAS Randomized Controlled Trial.

Joyeux-Faure M, Baguet JP, Barone-Rochette G, Faure P, Sosner P, Mounier-Vehier C, Lévy P, Tamisier R, Pépin JL.

Front Neurol. 2018 May 8;9:318. doi: 10.3389/fneur.2018.00318. eCollection 2018.

42.

Nasal Obstruction Symptom Evaluation Score to Guide Mask Selection in CPAP-Treated Obstructive Sleep Apnea.

Lebret M, Arnol N, Martinot JB, Tamisier R, Deschaux C, Pépin JL, Borel JC.

Otolaryngol Head Neck Surg. 2018 Sep;159(3):590-592. doi: 10.1177/0194599818773993. Epub 2018 Jun 5.

PMID:
29865942
43.

Ticagrelor and Central Sleep Apnea.

Revol B, Jullian-Desayes I, Tamisier R, Puel V, Mallaret M, Joyeux-Faure M, Pépin JL.

J Am Coll Cardiol. 2018 May 22;71(20):2378-2379. doi: 10.1016/j.jacc.2018.03.447. No abstract available.

44.

Maximal exercise capacity in patients with obstructive sleep apnoea syndrome: a systematic review and meta-analysis.

Mendelson M, Marillier M, Bailly S, Flore P, Borel JC, Vivodtzev I, Doutreleau S, Tamisier R, Pépin JL, Verges S.

Eur Respir J. 2018 Jun 28;51(6). pii: 1702697. doi: 10.1183/13993003.02697-2017. Print 2018 Jun.

45.

Neuromuscular Dysfunction and Cortical Impairment in Sleep Apnea Syndrome.

Marillier M, Gruet M, Baillieul S, LE Roux Mallouf T, Wuyam B, Tamisier R, Levy P, Pepin JL, Verges S.

Med Sci Sports Exerc. 2018 Aug;50(8):1529-1539. doi: 10.1249/MSS.0000000000001625.

PMID:
29613997
46.

Sleep biology updates: Hemodynamic and autonomic control in sleep disorders.

Tamisier R, Weiss JW, Pépin JL.

Metabolism. 2018 Jul;84:3-10. doi: 10.1016/j.metabol.2018.03.012. Epub 2018 Mar 21. Review.

PMID:
29572132
47.

Obstructive Sleep Apnea Syndrome, Objectively Measured Physical Activity and Exercise Training Interventions: A Systematic Review and Meta-Analysis.

Mendelson M, Bailly S, Marillier M, Flore P, Borel JC, Vivodtzev I, Doutreleau S, Verges S, Tamisier R, Pépin JL.

Front Neurol. 2018 Feb 22;9:73. doi: 10.3389/fneur.2018.00073. eCollection 2018.

48.

Severe central sleep apnoea associated with nalmefene: a case report.

Khouri C, Arbib F, Revol B, Pepin JL, Tamisier R.

Br J Clin Pharmacol. 2018 May;84(5):1075-1076. doi: 10.1111/bcp.13547. Epub 2018 Feb 26.

49.

Incorporating polysomnography into obstructive sleep apnoea phenotyping: moving towards personalised medicine for OSA.

Pépin JL, Bailly S, Tamisier R.

Thorax. 2018 May;73(5):409-411. doi: 10.1136/thoraxjnl-2017-210943. Epub 2018 Feb 24. No abstract available.

PMID:
29477990
50.

Continuous positive airway pressure improves gait control in severe obstructive sleep apnoea: A prospective study.

Baillieul S, Wuyam B, Pépin JL, Marillier M, Tamisier R, Pérennou D, Verges S.

PLoS One. 2018 Feb 23;13(2):e0192442. doi: 10.1371/journal.pone.0192442. eCollection 2018.

Supplemental Content

Loading ...
Support Center